Pharmacogenetics and metabolism of cyclophosphamide in paediatric non-Hodgkin’s Lymphoma - Cyclophosphamide in NH
Phase 1
- Conditions
- non-Hodgkin's Lymphoma
- Registration Number
- EUCTR2004-003731-31-GB
- Lead Sponsor
- niversity Hospitals of Leiceter NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
a) Age =18 years at diagnosis
b) Diagnosis of B-cell non-Hodgkin's lymphoma
c) Recieving cyclophosphamide as part of standard treatment
d) Single or double lumen canteral venous catheter in place
e) Written informed consent
f) Protocol approval by national and local ethics committee
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Failure to complile with any of the inclusion criteria
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method